Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multi-centre Study of the Ellume® Respirio Flu Test and the Ellume® eLab Flu Test Performance Versus Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) for the Rapid Detection of Influenza A/B

NCT02767414 is registered in ClinicalTrials.gov with Ellume Pty Ltd as lead sponsor.

NCT NCT02767414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02767414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multi-centre Study of the Ellume® Respirio Flu Test and the Ellume® eLab Flu Test Performance Versus Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) for the Rapid Detection of Influenza A/B
Lead sponsor
Ellume Pty Ltd
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2016
Completion date
October 31, 2016
Enrollment
1,500 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

influenza a, influenza b